Bright Minds Biosciences (DRUG) Income towards Parent Company (2019 - 2026)
Bright Minds Biosciences (DRUG) posted Income towards Parent Company of -$1.73 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with $3.78 million a year earlier.
Powered by 
Analysis
Bright Minds Biosciences (DRUG) Income towards Parent Company (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Income towards Parent Company at Bright Minds Biosciences was $4.14 million, up 0.7% year-over-year; for FY2025 (ended Sep 30, 2025), it was -$8.75 million.
- In prior fiscal years, Bright Minds Biosciences' Income towards Parent Company was -$2.06 million in FY2024, $1.06 million in FY2023, -$11.72 trillion in FY2022 and -$6.84 trillion in FY2021.
- Quarterly Income towards Parent Company has run from a low of -$6.87 trillion in fiscal Q4 2021 to a high of $20.77 million in fiscal Q2 2026 over five years.
- According to Business Quant data, Income towards Parent Company for the three prior fiscal quarters was $20.77 million (Q2 2026), -$6.01 million (Q1 2026) and -$8.89 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Bright Minds Biosciences | 387.06 Mn | 387.06 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.73 Mn |
| Mar 31, 2026 | 20.77 Mn |
| Dec 31, 2025 | -6.01 Mn |
| Sep 30, 2025 | -8.89 Mn |
| Jun 30, 2025 | 3.78 Mn |
| Mar 31, 2025 | 2.35 Mn |
| Dec 31, 2024 | 32,422.24 |
| Sep 30, 2024 | -2.05 Mn |
| Jun 30, 2024 | 302,577.40 |
| Mar 31, 2024 | -426,077.62 |
| Dec 31, 2023 | 1.24 Mn |
| Sep 30, 2023 | 1.07 Mn |
| Jun 30, 2023 | -1.09 Mn |
| Mar 31, 2023 | 1.52 Mn |
| Dec 31, 2022 | 1.72 Mn |
| Sep 30, 2022 | 2.27 Mn |
| Jun 30, 2022 | 2.09 Mn |
| Mar 31, 2022 | -3.54 Mn |
| Dec 31, 2021 | 3.85 Mn |
| Sep 30, 2021 | -6,872.25 Bn |
API Access
Bright Minds Biosciences Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=DRUG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "DRUG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=DRUG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();